ArticleJournal of stroke and cerebrovascular diseases : the official journal of National Stroke Association2022

Rationale and design of the AXIOMATIC-SSP phase II trial: Antithrombotic treatment with factor XIa inhibition to Optimize Management of Acute Thromboembolic events for Secondary Stroke Prevention.

Mukul Sharma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.